{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:11:27Z","timestamp":1793211087194,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s13760-019-01239-8","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T08:21:56Z","timestamp":1573633316000},"page":"515-519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Valproate-induced rest tremor and parkinsonism"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8614-5563","authenticated-orcid":false,"given":"Jos\u00e9 Fidel","family":"Baizabal-Carvallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Alonso-Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,13]]},"reference":[{"key":"1239_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.parkreldis.2017.09.011","volume":"44","author":"M Alonso-Juarez","year":"2017","unstructured":"Alonso-Juarez M, Torres-Russotto D, Crespo-Morfin P, Baizabal-Carvallo JF (2017) The clinical features and functional impact of valproate-induced tremor. Parkinsonism Relat Disord 44:147\u2013150","journal-title":"Parkinsonism Relat Disord"},{"key":"1239_CR2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/mds.21412","volume":"22","author":"MA Stacy","year":"2007","unstructured":"Stacy MA, Elble RJ, Ondo WG, Wu SC, Hulihan J (2007) TRS study group, assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin tremor rating scale in essential tremor. Mov Disord 22:833\u2013838","journal-title":"Mov Disord"},{"key":"1239_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/archneur.60.3.405","volume":"60","author":"O Cohen","year":"2003","unstructured":"Cohen O, Pullman S, Jurewicz E, Watner D, Louis ED (2003) Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics. Arch Neurol 60:405\u2013410","journal-title":"Arch Neurol"},{"key":"1239_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/ane.12953","volume":"138","author":"M Alonso-Juarez","year":"2018","unstructured":"Alonso-Juarez M, Baizabal-Carvallo JF (2018) Distinguishing features between valproate-induced tremor and essential tremor. Acta Neurol Scand 138:177\u2013181","journal-title":"Acta Neurol Scand"},{"key":"1239_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S1474-4422(05)70250-7","volume":"4","author":"JC Morgan","year":"2005","unstructured":"Morgan JC, Sethi KD (2005) Drug-induced tremors. Lancet Neurol 4:866\u2013876","journal-title":"Lancet Neurol"},{"issue":"3","key":"1239_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/00207454.2016.1181631","volume":"127","author":"SA Hamed","year":"2017","unstructured":"Hamed SA, Abdellah MM (2017) The relationship between valproate induced tremors and circulating neurotransmitters: a preliminary study. Int J Neurosci 127(3):236\u2013242","journal-title":"Int J Neurosci"},{"key":"1239_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/jnnp.2006.100222","volume":"78","author":"C Zadikoff","year":"2007","unstructured":"Zadikoff C, Munhoz RP, Asante AN et al (2007) Movement disorders in patients taking anticonvulsants. J Neurol Neurosurg Psychiatry 78:147\u2013151","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1239_CR8","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1111\/j.1528-1167.2006.00711.x","volume":"47","author":"AJ Risti\u0107","year":"2006","unstructured":"Risti\u0107 AJ, Vojvodi\u0107 N, Jankovi\u0107 S, Sindeli\u0107 A, Soki\u0107 D (2006) The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia 47:2183\u20132185","journal-title":"Epilepsia"},{"key":"1239_CR9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/WNL.47.3.626","volume":"47","author":"C Armon","year":"1996","unstructured":"Armon C, Shin C, Miller P, Carwile S, Brown E, Edinger JD, Paul RG (1996) Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 47:626\u2013635","journal-title":"Neurology"},{"key":"1239_CR10","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1212\/01.WNL.0000121228.32913.00","volume":"62","author":"K Easterford","year":"2004","unstructured":"Easterford K, Clough P, Kellett M, Fallon K, Duncan S (2004) Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. Neurology 62:1435\u20131437","journal-title":"Neurology"},{"key":"1239_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mds.21188","volume":"22","author":"D Jamora","year":"2007","unstructured":"Jamora D, Lim SH, Pan A, Tan L, Tan EK (2007) Valproate-induced parkinsonism in epilepsy patients. Mov Disord 22:130\u2013133","journal-title":"Mov Disord"},{"key":"1239_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.parkreldis.2013.03.016","volume":"19","author":"M Silver","year":"2013","unstructured":"Silver M, Factor SA (2013) Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia. Parkinsonism Relat Disord 19:758\u2013760","journal-title":"Parkinsonism Relat Disord"},{"key":"1239_CR13","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s004150050288","volume":"245","author":"M Onofrj","year":"1998","unstructured":"Onofrj M, Thomas A, Paci C (1998) Reversible parkinsonism induced by prolonged treatment with valproate. J Neurol 245:794\u2013796","journal-title":"J Neurol"},{"key":"1239_CR14","first-page":"343","volume":"44","author":"K Gale","year":"1986","unstructured":"Gale K (1986) Role of the substantia nigra in GABA-mediated anticonvulsant actions. Adv Neurol 44:343\u2013364","journal-title":"Adv Neurol"},{"key":"1239_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0079-6123(06)60011-3","volume":"160","author":"JM Tepper","year":"2007","unstructured":"Tepper JM, Lee CR (2007) GABAergic control of substantia nigra dopaminergic neurons. Prog Brain Res 160:189\u2013208","journal-title":"Prog Brain Res"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-019-01239-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-019-01239-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-019-01239-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T14:05:35Z","timestamp":1615730735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-019-01239-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,13]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1239"],"URL":"https:\/\/doi.org\/10.1007\/s13760-019-01239-8","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,13]]},"assertion":[{"value":"11 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors confirm that the approval of the institutional review board was obtained for this work. We confirm that we have read the journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}